BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

946 related articles for article (PubMed ID: 9184795)

  • 21. Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells.
    Stein U; Lage H; Jordan A; Walther W; Bates SE; Litman T; Hohenberger P; Dietel M
    Int J Cancer; 2002 Feb; 97(6):751-60. PubMed ID: 11857350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involvement of glutathione in loss of technetium-99m-MIBI accumulation related to membrane MDR protein expression in tumor cells.
    Moretti JL; Duran Cordobes M; Starzec A; de Beco V; Vergote J; Benazzouz F; Boissier B; Cohen H; Safi N; Piperno-Neumann S; Kouyoumdjian JC
    J Nucl Med; 1998 Jul; 39(7):1214-8. PubMed ID: 9669397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MRP is frequently expressed in human lung-cancer cell lines, in non-small-cell lung cancer and in normal lungs.
    Giaccone G; van Ark-Otte J; Rubio GJ; Gazdar AF; Broxterman HJ; Dingemans AM; Flens MJ; Scheper RJ; Pinedo HM
    Int J Cancer; 1996 Jun; 66(6):760-7. PubMed ID: 8647646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence for functional discrimination between leukemic cells overexpressing multidrug-resistance associated protein and P-glycoprotein.
    Benderra Z; Morjani H; Trussardi A; Manfait M
    Adv Exp Med Biol; 1999; 457():151-60. PubMed ID: 10500790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diverse effects of P-glycoprotein inhibitory agents on human leukemia cells expressing the multidrug resistance protein (MRP).
    Lehne G; Mørkrid L; den Boer M; Rugstad HE
    Int J Clin Pharmacol Ther; 2000 Apr; 38(4):187-95. PubMed ID: 10783828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterisation of multidrug-resistant Ehrlich ascites tumour cells selected in vivo for resistance to etoposide.
    Nielsen D; Maare C; Eriksen J; Litman T; Friche E; Skovsgaard T
    Biochem Pharmacol; 2000 Aug; 60(3):353-61. PubMed ID: 10856430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the clinical relevance of the expression and function of P-glycoprotein, multidrug resistance protein and lung resistance protein in patients with primary acute myelogenous leukemia.
    Tsimberidou AM; Paterakis G; Androutsos G; Anagnostopoulos N; Galanopoulos A; Kalmantis T; Meletis J; Rombos Y; Sagriotis A; Symeonidis A; Tiniakou M; Zoumbos N; Yataganas X
    Leuk Res; 2002 Feb; 26(2):143-54. PubMed ID: 11755464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein kinase inhibitor-induced alterations of drug uptake, cell cycle and surface antigen expression in human multidrug-resistant (Pgp and MRP) promyelocytic leukemia HL-60 cells.
    Sedlák J; Hunáková L; Suliková M; Chorváth B
    Leuk Res; 1997 May; 21(5):449-58. PubMed ID: 9225074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of the multidrug resistance genes mdr1, mdr3, and mrp in L1210 leukemia cells resistant to inhibitors of ribonucleotide reductase.
    Rappa G; Lorico A; Liu MC; Kruh GD; Cory AH; Cory JG; Sartorelli AC
    Biochem Pharmacol; 1997 Sep; 54(6):649-55. PubMed ID: 9310341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of drug resistance genes in VP-16 and mAMSA-selected human carcinoma cells.
    Matsumoto Y; Takano H; Kunishio K; Nagao S; Fojo T
    Jpn J Cancer Res; 2001 Jul; 92(7):778-84. PubMed ID: 11473729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered MRP is associated with multidrug resistance and reduced drug accumulation in human SW-1573 cells.
    Eijdems EW; Zaman GJ; de Haas M; Versantvoort CH; Flens MJ; Scheper RJ; Kamst E; Borst P; Baas F
    Br J Cancer; 1995 Aug; 72(2):298-306. PubMed ID: 7640209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein.
    Zaman GJ; Lankelma J; van Tellingen O; Beijnen J; Dekker H; Paulusma C; Oude Elferink RP; Baas F; Borst P
    Proc Natl Acad Sci U S A; 1995 Aug; 92(17):7690-4. PubMed ID: 7644478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overlapping phenotypes of multidrug resistance among panels of human cancer-cell lines.
    Izquierdo MA; Shoemaker RH; Flens MJ; Scheffer GL; Wu L; Prather TR; Scheper RJ
    Int J Cancer; 1996 Jan; 65(2):230-7. PubMed ID: 8567122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemical synthesis and biological properties of novel fluorescent antifolates in Pgp- and MRP-overexpressing tumour cell lines.
    Robson C; Wright KA; Twentyman PR; Lambert PA; Griffin RJ
    Biochem Pharmacol; 1998 Oct; 56(7):807-16. PubMed ID: 9774142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
    Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
    Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemotherapy induces or increases expression of multidrug resistance-associated protein in malignant melanoma cells.
    Ichihashi N; Kitajima Y
    Br J Dermatol; 2001 Apr; 144(4):745-50. PubMed ID: 11298532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multidrug resistance: retrospect and prospects in anti-cancer drug treatment.
    Pérez-Tomás R
    Curr Med Chem; 2006; 13(16):1859-76. PubMed ID: 16842198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetic analysis of calcein and calcein-acetoxymethylester efflux mediated by the multidrug resistance protein and P-glycoprotein.
    Essodaigui M; Broxterman HJ; Garnier-Suillerot A
    Biochemistry; 1998 Feb; 37(8):2243-50. PubMed ID: 9485370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between cytotoxic drug response patterns and activity of drug efflux transporters mediating multidrug resistance.
    Dhar S; Nygren P; Liminga G; Sundström C; de la Torre M; Nilsson K; Larsson R
    Eur J Pharmacol; 1998 Apr; 346(2-3):315-22. PubMed ID: 9652375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro and in vivo evaluation of WK-X-34, a novel inhibitor of P-glycoprotein and BCRP, using radio imaging techniques.
    Jekerle V; Klinkhammer W; Scollard DA; Breitbach K; Reilly RM; Piquette-Miller M; Wiese M
    Int J Cancer; 2006 Jul; 119(2):414-22. PubMed ID: 16646006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.